Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies

$NUWEPress releaseJul 16, 2026, 8:30 AM ETRead the release

Nuwellis announced the issuance of U.S. Patent No. 12,678,592 covering its Dual Lumen Catheter, designed for use in ultrafiltration, dialysis, and CRRT therapies. The patented design features a reinforcing stainless-steel coil to prevent catheter collapse and allows clinicians to trim the device to patient-specific lengths without losing structural integrity.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.